Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Stephen J. Greene"'
Publikováno v:
Heart Failure Reviews. 27:741-753
In clinical practice, many patients with heart failure with reduced ejection fraction (HFrEF) are either not prescribed guideline-directed medical therapies for which they are eligible or are prescribed therapies at sub-target doses. The objective of
Autor:
Stephen J, Greene, Xi, Tan, Yu-Chen, Yeh, Mark, Bernauer, Omer, Zaidi, Mei, Yang, Javed, Butler
Publikováno v:
Heart failure reviews. 27(3)
In clinical practice, many patients with heart failure with reduced ejection fraction (HFrEF) are either not prescribed guideline-directed medical therapies for which they are eligible or are prescribed therapies at sub-target doses. The objective of
Autor:
Baljash Cheema, Sean P. Collins, Alexandre Mebazaa, Javed Butler, Muthiah Vaduganathan, Mihai Gheorghiade, Joyce N. Njoroge, Ovidiu Chioncel, Stephen J. Greene, Andrew P. Ambrosy
Publikováno v:
Heart Failure Reviews. 23:597-607
Heart failure is a complex disease process, the manifestation of various cardiac and noncardiac abnormalities. General treatment approaches for heart failure have remained the same over the past decades despite the advent of novel therapies and monit
Autor:
Michael Böhm, Sean P. Collins, Piotr Ponikowski, Gregg C. Fonarow, Hani N. Sabbah, Mihai Gheorghiade, Stephen J. Greene, John C. Burnett, Umberto Campia, Naoki Sato, Lothar Roessig, Javed Butler, John G.F. Cleland, Marco Metra, Phillip D. Levy, Bertram Pitt, Johannes-Peter Stasch, Adriaan A. Voors, Catherine N. Marti
Publikováno v:
Heart failure reviews, 18(2), 123-134. SPRINGER
The number of annual hospitalizations for heart failure (HF) and the mortality rates among patients hospitalized for HF remains unacceptably high. The search continues for safe and effective agents that improve outcomes when added to standard therapy
Autor:
Barbara Albrecht-Küpper, Hani N. Sabbah, Javed Butler, Adriaan A. Voors, Hans-Dirk Düngen, Stephen J. Greene, Mihai Gheorghiade, Wilfried Dinh
Publikováno v:
Heart failure reviews, 21(1), 95-102. SPRINGER
Heart failure (HF) represents a global public health and economic problem associated with unacceptable rates of death, hospitalization, and healthcare expenditure. Despite available therapy, HF carries a prognosis comparable to many forms of cancer w
Autor:
Marco Metra, Gerasimos Filippatos, Muthiah Vaduganathan, Stuart Kupfer, Gadi Cotter, Lothar Roessig, Mihai Gheorghiade, Gregg C. Fonarow, Andrew Zalewski, Naoki Sato, Javed Butler, Stephen J. Greene
Publikováno v:
Heart failure reviews. 20(4)
With one possible exception, the last decade of clinical trials in hospitalized heart failure (HHF) patients has failed to demonstrate improvement in long-term clinical outcomes. This trend necessitates a need to evaluate optimal drug development str
Publikováno v:
Heart failure reviews. 19(6)
Lower serum lipid levels are paradoxically predictive of poor clinical outcomes in hospitalized and ambulatory patients with heart failure (HF). In large randomized controlled trials, statins did not demonstrate an overall mortality benefit in chroni
Autor:
Muthiah Vaduganathan, Gregory Y.H. Lip, Stephen J. Greene, Javed Butler, Eduard Shantsila, Hani N. Sabbah, Mihai Gheorghiade
Publikováno v:
Heart failure reviews. 18(6)
The important role of the immune system and inflammation in the pathophysiology of heart failure (HF) is becoming increasingly appreciated. We have reviewed the prognostic significance of under-recognized aspects of the leukocyte differential in HF,